- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/541 - Double or second antibody
Patent holdings for IPC class G01N 33/541
Total number of patents in this class: 124
10-year publication summary
|
8
|
5
|
13
|
18
|
14
|
8
|
5
|
9
|
1
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bio-Rad Laboratories, Inc. | 1619 |
4 |
| Charles River Laboratories International, Inc | 19 |
4 |
| F. Hoffmann-La Roche AG | 7934 |
3 |
| Roche Diagnostics Operations, Inc. | 1509 |
3 |
| DiaSorin S.p.A. | 66 |
3 |
| Intrinsic Lifesciences LLC | 16 |
3 |
| Siemens Healthcare Diagnostics Inc. | 2101 |
3 |
| S D Systems, Inc. | 4 |
3 |
| Becton, Dickinson and Company | 7415 |
2 |
| Board of Regents, The University of Texas System | 5927 |
2 |
| Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 285 |
2 |
| Children's Medical Center Corporation | 1909 |
2 |
| Chrome Red Technologies, LLC | 8 |
2 |
| EDP Biotech Corporation | 8 |
2 |
| Eli Lilly and Company | 3911 |
2 |
| IDEXX Laboratories, Inc. | 858 |
2 |
| Sekisui Medical Co., Ltd. | 670 |
2 |
| STEMCELL Technologies Canada Inc. | 287 |
2 |
| Sysmex Corporation | 1434 |
2 |
| University of Manitoba | 450 |
2 |
| Other owners | 74 |